Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGF Antikörper (AA 27-233)

VEGF Reaktivität: Human, Hund WB, IHC Wirt: Maus Monoclonal 4G3 unconjugated
Produktnummer ABIN2735205
  • Target Alle VEGF Antikörper anzeigen
    VEGF (Vascular Endothelial Growth Factor (VEGF))
    Bindungsspezifität
    • 16
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 27-233
    Reaktivität
    • 79
    • 47
    • 35
    • 18
    • 16
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Hund
    Wirt
    • 53
    • 25
    • 12
    • 2
    • 2
    • 1
    Maus
    Klonalität
    • 59
    • 33
    • 1
    Monoklonal
    Konjugat
    • 42
    • 13
    • 7
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VEGF Antikörper ist unkonjugiert
    Applikation
    • 79
    • 55
    • 23
    • 19
    • 15
    • 14
    • 12
    • 9
    • 9
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Aufreinigung
    Purified from mouse ascites fluids by affinity chromatography
    Immunogen
    Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
    Klon
    4G3
    Isotyp
    IgG2b
    Top Product
    Discover our top product VEGF Primärantikörper
  • Applikationshinweise
    WB 1:2500~5000, IHC: 1:50-1:150,
    Kommentare

    The concentration of the product may vary between diferrent lots.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5-1.0 mg/mL
    Buffer
    PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Chen, Tang, Feng, Li, Xiang, He, Ren, Peng, Xiang: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).

    Shao, Feng, Zhang, Yu, Li, Tan, Xu, Ying, Li, Yang, Peng, Tang, Li, Ren, Tao, Xiang: "The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer." in: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1257-1271, (2018) (PubMed).

  • Target
    VEGF (Vascular Endothelial Growth Factor (VEGF))
    Andere Bezeichnung
    VEGF (VEGF Produkte)
    Synonyme
    MVCD1 antikoerper, VEGF antikoerper, VPF antikoerper, Vegf antikoerper, Vegf120 antikoerper, Vegf164 antikoerper, Vegf188 antikoerper, Vpf antikoerper, VEGF-A antikoerper, VEGF164 antikoerper, eVEGF120 antikoerper, eVEGF164 antikoerper, vegf-a antikoerper, vegf antikoerper, vascular endothelial growth factor A antikoerper, vascular endothelial growth factor A L homeolog antikoerper, vascular endothelial growth factor antikoerper, vascular endothelial growth factor precursor antikoerper, VEGFA antikoerper, Vegfa antikoerper, vegfa.L antikoerper, VEGF antikoerper, vegf antikoerper
    Molekulargewicht
    23.8 kDa
    Gen-ID
    7422
    NCBI Accession
    NM_001025366
    HGNC
    7422
Sie sind hier:
Kundenservice